CAS 2178049-58-4

ACT-1004-1239

CAS: 2178049-58-4

ACT-1004-1239

Pureza: ≥98%

Peso molecular: 522.55g/mol

Ref: 54-BUP21165

ACT-1004-1239

CAS: 2178049-58-4

ACT-1004-1239 is a CXCR7 antagonist with immunomodulatory and myelination-promoting effects, used for research on inflammatory demyelinating diseases.

Fórmula: C₂₇H₂₈F₂N₆O₃

Pureza: 98.31%

Cor e Forma: Solid

Peso molecular: 522.55

Ref: TM-T39665